Literature DB >> 1336049

Characteristics and utilization of antibody measurements in clinical studies of periodontal disease.

J L Ebersole1, D Cappelli, M J Steffen.   

Abstract

The detection and quantitation of immune responses to infections have long been used as a diagnostic tool in medical infections. Recently, increasing evidence has supported that active, specific antibody responses to selected members of the subgingival microbiota are noted in periodontitis patients. This report describes the various specificities of this antibody as they relate to periodontitis classification and prognosis. The functional aspects of the serum antibody have come under increasing scrutiny to understand better the potential immunologic mechanisms acting in the periodontium. Data are available that describe opsonizing potential, complement fixing ability, blocking functions, and anti-toxic capacity for the antibody. Longitudinal alterations in specific antibody levels are shown to relate to infection and accompany changes in the burden of a specific microorganism in the subgingival plaque. Thus, these antibody changes could be useful indicators of altered host-parasite interactions that presage a disease-active episode. Finally, studies were designed to examine the ability of antibody to reflect the effects of treatment on the disease. The results indicated that specific antibody levels change with mechanical, antimicrobial, and anti-inflammatory treatments. The findings described in this report suggest that evaluation of the level and specificity of serum antibody can be a beneficial adjunct in designing and implementing clinical studies delineating the initiation, progression, and treatment of periodontitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336049     DOI: 10.1902/jop.1992.63.12s.1110

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  10 in total

1.  Systemic inflammatory responses in progressing periodontitis during pregnancy in a baboon model.

Authors:  J L Ebersole; M J Steffen; S C Holt; L Kesavalu; L Chu; D Cappelli
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

2.  Periodontitis in pregnancy: clinical and serum antibody observations from a baboon model of ligature-induced disease.

Authors:  D Cappelli; M J Steffen; S C Holt; J L Ebersole
Journal:  J Periodontol       Date:  2009-07       Impact factor: 6.993

3.  Humoral immune responses in periodontal disease may have mucosal and systemic immune features.

Authors:  D F Kinane; D F Lappin; O Koulouri; A Buckley
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 4.  Mechanisms involved in the association between periodontal diseases and cardiovascular disease.

Authors:  R Teles; C-Y Wang
Journal:  Oral Dis       Date:  2011-01-11       Impact factor: 3.511

5.  [Oral manifestations in patients with systemic lupus erythematosus].

Authors:  U Meyer; J Kleinheinz; M Gaubitz; M Schulz; D Weingart; U Joos
Journal:  Mund Kiefer Gesichtschir       Date:  1997-03

6.  Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease.

Authors:  Pamela Sparks Stein; Michelle J Steffen; Charles Smith; Gregory Jicha; Jeffrey L Ebersole; Erin Abner; Dolph Dawson
Journal:  Alzheimers Dement       Date:  2012-05       Impact factor: 21.566

7.  Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis.

Authors:  J Mooney; E Adonogianaki; M P Riggio; K Takahashi; A Haerian; D F Kinane
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Differential gender effects of a reduced-calorie diet on systemic inflammatory and immune parameters in nonhuman primates.

Authors:  J L Ebersole; M J Steffen; M A Reynolds; G L Branch-Mays; D R Dawson; K F Novak; J C Gunsolley; J A Mattison; D K Ingram; M J Novak
Journal:  J Periodontal Res       Date:  2008-06-28       Impact factor: 4.419

9.  Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients.

Authors:  Harini Bagavant; Micah L Dunkleberger; Nina Wolska; Magdalena Sroka; Astrid Rasmussen; Indra Adrianto; Courtney Montgomery; Kathy Sivils; Joel M Guthridge; Judith A James; Joan T Merrill; Umesh S Deshmukh
Journal:  Clin Exp Rheumatol       Date:  2018-06-25       Impact factor: 4.862

10.  Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.

Authors:  Hai-Fang Wang; Lin-Fang Li; Song-He Guo; Qiu-Yao Zeng; Fen Ning; Wan-Li Liu; Ge Zhang
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.